Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study (Q48022229)
Jump to navigation
Jump to search
scientific article published on 10 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study |
scientific article published on 10 April 2009 |
Statements
1 reference
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study (English)
1 reference
1 reference
Kensei Tobinai
1 reference
Noriko Usui
1 reference
Akihiro Takeshita
1 reference
Kensuke Naito
1 reference
Osamu Asai
1 reference
Nobuaki Dobashi
1 reference
Shinpei Furusawa
1 reference
Kenji Saito
1 reference
Kinuko Mitani
1 reference
Yasuo Morishima
1 reference
Michinori Ogura
1 reference
Fumiaki Yoshiba
1 reference
Tomomitsu Hotta
1 reference
Masami Bessho
1 reference
Shin Matsuda
1 reference
Jin Takeuchi
1 reference
Shuichi Miyawaki
1 reference
Tomoki Naoe
1 reference
Ryuzo Ohno
1 reference
10 April 2009
1 reference
89
1 reference
4
1 reference
460-469
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference